fda removes semaglutide from shortage list As of February 21, 2025, the updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A UPDATED: FDA lists all doses

These medicines include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon)

Employer Strategies: How to Manage GLP-1 Costs Without Destroying Morale If you decide to cover GLP-1 drugsor if you are already covering them and costs are spiralingyou are not without options

Gradual, steady loss is what tends to last

Holly Lofton (NYU Langone Health) details the overwhelming demand for these drugs, even among those not strictly medically eligible

The timing strategy for constipation is less about when you inject and more about what you do in the 48 hours after injection